Conference Coverage
Conference Coverage
Eat more dairy, less red meat to prevent type 2 diabetes
Not all animal foods are alike when it comes to their association with type 2 diabetes risk, shows a large new review. The devil is in the details...
Conference Coverage
PASCAL for MV repair noninferior to MitraClip in CLASP IID; FDA took notice
A newly FDA-approved transcatheter mitral valve repair system and another one widely used for years were similarly safe and effective in an...
Conference Coverage
Whole grains may improve survival in people with type 2 diabetes
Fish, whole grain, fiber, and polyunsaturated fats are found to reduce premature death in a large overview of studies in people with type 2...
Conference Coverage
Frailty poses no limit to HFpEF meds
Sacubitril/valsartan worked as well or better in frail patients with HFpEF compared with those less frail. Recent dapagliflozin data show this as...
Conference Coverage
Waist-hip ratio beats BMI for predicting obesity’s mortality risk
Data from more than 380,000 people in the UK Biobank show waist-to-hip ratio estimated mortality risk from obesity better than BMI or fat mass...
Conference Coverage
A week of anticoagulation halves post-PCI radial occlusion rate
Seven days of a factor Xa inhibitor following a radial-access intervention reduces radial occlusion risk.
Conference Coverage
Is acetaminophen really safer than NSAIDs in heart disease?
A new analysis finds a significant correlation between acetaminophen use and elevated systolic blood pressure.
Conference Coverage
‘Game changer’ semaglutide halves diabetes risk from obesity
Post-hoc analysis of two semaglutide trials in people with obesity showed treatment cut their projected 10-year risk for incident type 2 diabetes...
Conference Coverage
Continuous cuffless monitoring may fuel lifestyle change to lower BP
Persistent BP monitoring with a wrist device was associated with a significant and sustained reduction in systolic BP among hypertensive patients...
Conference Coverage
Ultrasonic renal denervation passes 2-month test in uncontrolled HTN: RADIANCE II
No ill effects were seen in the sham-controlled trial of patients with uncontrolled mild to moderate hypertension. The approach led to significant...
Conference Coverage
TAVR now used in almost 50% of younger severe aortic stenosis patients
These findings have implications for lifetime management of younger patients who undergo TAVR.